OptimizeRx (OPRX) News Today → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free OPRX Stock Alerts $12.66 -0.28 (-2.16%) (As of 05/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 27 at 11:36 PM | marketbeat.comMillrace Asset Group Inc. Purchases Shares of 133,936 OptimizeRx Co. (NASDAQ:OPRX)Millrace Asset Group Inc. purchased a new stake in OptimizeRx Co. (NASDAQ:OPRX - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 133,936 shares of the company's stock, valued aMay 19, 2024 | americanbankingnews.comOptimizeRx (NASDAQ:OPRX) Price Target Raised to $16.00May 15, 2024 | finanznachrichten.deOptimizeRx Corporation: OptimizeRx Reports First Quarter 2024 Financial ResultsMay 15, 2024 | marketwatch.comOptimizeRx Shares Rise 23% on 1Q Revenue Beat, FY GuidanceMay 15, 2024 | markets.businessinsider.comStifel Nicolaus Reaffirms Their Buy Rating on OptimizeRx (OPRX)May 15, 2024 | msn.comOptimizeRx Corporation (NASDAQ:OPRX) Q1 2024 Earnings Call TranscriptMay 15, 2024 | marketbeat.comOptimizeRx (NASDAQ:OPRX) PT Raised to $16.00 at JMP SecuritiesJMP Securities boosted their price target on OptimizeRx from $15.00 to $16.00 and gave the company a "market outperform" rating in a research report on Wednesday.May 15, 2024 | marketbeat.comOptimizeRx (NASDAQ:OPRX) Issues Quarterly Earnings Results, Misses Estimates By $0.16 EPSOptimizeRx (NASDAQ:OPRX - Get Free Report) issued its earnings results on Tuesday. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.16). The firm had revenue of $19.69 million during the quarter, compared to analysts' expectations of $18.66 million. OptimizeRx had a negative return on equity of 7.72% and a negative net margin of 24.56%. During the same period last year, the firm posted ($0.34) earnings per share.May 15, 2024 | marketbeat.comStifel Nicolaus Reiterates Buy Rating for OptimizeRx (NASDAQ:OPRX)Stifel Nicolaus reiterated a "buy" rating and set a $13.00 price objective on shares of OptimizeRx in a report on Wednesday.May 15, 2024 | finance.yahoo.comOptimizeRx Corp (OPRX) Q1 2024 Earnings Call Transcript Highlights: Surging Revenues and ...May 14, 2024 | investorplace.comOPRX Stock Earnings: OptimizeRx Beats EPS, Beats Revenue for Q1 2024May 14, 2024 | globenewswire.comOptimizeRx Reports First Quarter 2024 Financial ResultsMay 7, 2024 | marketbeat.comOptimizeRx (OPRX) Set to Announce Earnings on TuesdayOptimizeRx (NASDAQ:OPRX) will be releasing earnings after the market closes on Tuesday, May 14, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=590375)May 6, 2024 | globenewswire.comOptimizeRx to Participate in Upcoming Investor ConferencesApril 29, 2024 | markets.businessinsider.comBuy Rating Reaffirmed for AbbVie: Future Growth Beyond Humira’s CompetitionApril 28, 2024 | marketbeat.comFederated Hermes Inc. Has $2.62 Million Holdings in OptimizeRx Co. (NASDAQ:OPRX)Federated Hermes Inc. lowered its position in shares of OptimizeRx Co. (NASDAQ:OPRX - Free Report) by 47.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 182,985 shares of the company's stock after selling 1April 26, 2024 | globenewswire.comOptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ETApril 18, 2024 | globenewswire.comOptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) ReportApril 16, 2024 | marketbeat.comOptimizeRx (NASDAQ:OPRX) Earns "Market Outperform" Rating from JMP SecuritiesJMP Securities reissued a "market outperform" rating and set a $15.00 price target on shares of OptimizeRx in a report on Tuesday.April 16, 2024 | globenewswire.comOptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial ResultsApril 13, 2024 | stockhouse.comOptimizeRx Named America's Fastest-Growing Company for Fifth Year in a RowApril 11, 2024 | finance.yahoo.comOptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a RowApril 11, 2024 | finance.yahoo.comOptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a RowApril 11, 2024 | globenewswire.comOptimizeRx Named America's Fastest-Growing Company for Fifth Year in a RowApril 6, 2024 | investorplace.com7 Top Undervalued Stocks Primed for a Multibagger RecoveryApril 4, 2024 | markets.businessinsider.comOptimizeRx: A Strong Buy on Strategic Acquisitions and Innovative Platform ExpansionApril 4, 2024 | marketbeat.comJMP Securities Begins Coverage on OptimizeRx (NASDAQ:OPRX)JMP Securities started coverage on shares of OptimizeRx in a report on Thursday. They issued an "outperform" rating and a $15.00 price objective on the stock.April 2, 2024 | au.lifestyle.yahoo.comTesla blames sales drop on Houthi attacks and arson in GermanyApril 1, 2024 | msn.comAriana Madix To Host ‘Love Island USA’ as Sarah Hyland Departs FranchiseApril 1, 2024 | au.news.yahoo.comCanoo spent double its annual revenue on the CEO’s private jet in 2023April 1, 2024 | finance.yahoo.comOptimizeRx Corporation (NASDAQ:OPRX) Q4 2023 Earnings Call TranscriptApril 1, 2024 | marketbeat.comOptimizeRx (NASDAQ:OPRX) Stock Rating Reaffirmed by Stifel NicolausStifel Nicolaus reissued a "buy" rating and set a $13.00 price target on shares of OptimizeRx in a report on Monday.March 29, 2024 | finance.yahoo.comQ4 2023 OPTIMIZERx Corp Earnings CallMarch 28, 2024 | investorplace.comOPRX Stock Earnings: OptimizeRx Beats Revenue for Q4 2023March 28, 2024 | msn.comOptimizeRx Q4 revenue $28.4MMarch 27, 2024 | msn.comOptimizeRx Q4 2023 Earnings PreviewMarch 27, 2024 | benzinga.com7OPRX : OptimizeRx Earnings PreviewMarch 25, 2024 | globenewswire.comOptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ETMarch 23, 2024 | seekingalpha.comOptimizeRx: Exponential Growth Drives The Valuation CheaperMarch 13, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), AnaptysBio (ANAB) and REPRO-MED Systems (KRMD)March 11, 2024 | markets.businessinsider.comOptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023March 11, 2024 | globenewswire.comOptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023March 8, 2024 | marketbeat.comKennedy Capital Management LLC Buys Shares of 555,675 OptimizeRx Co. (NASDAQ:OPRX)Kennedy Capital Management LLC purchased a new position in OptimizeRx Co. (NASDAQ:OPRX - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 555,675 shares of the company's stock, valued at approximately $March 6, 2024 | stockhouse.comOptimizeRx Powers Walmart's 'Specialty Pharmacies of the Community' Outreach EffortMarch 4, 2024 | globenewswire.comOptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community' Outreach EffortMarch 2, 2024 | marketbeat.comOptimizeRx Co. (NASDAQ:OPRX) Stock Holdings Lowered by Avenir CorpAvenir Corp lowered its position in shares of OptimizeRx Co. (NASDAQ:OPRX - Free Report) by 19.4% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 307,549 shares of the company's stock after selling 74,111 shares during the period. OptimizeRx accounts for 0.February 23, 2024 | benzinga.comOptimizeRx Stock (NASDAQ:OPRX), Short Interest ReportFebruary 21, 2024 | globenewswire.comOptimizeRx to Participate in Upcoming Investor ConferencesFebruary 13, 2024 | marketbeat.comOptimizeRx Co. (NASDAQ:OPRX) Short Interest Down 19.6% in JanuaryOptimizeRx Co. (NASDAQ:OPRX - Get Free Report) saw a significant decrease in short interest in January. As of January 31st, there was short interest totalling 778,800 shares, a decrease of 19.6% from the January 15th total of 968,400 shares. Based on an average daily trading volume, of 163,900 shares, the days-to-cover ratio is currently 4.8 days. Currently, 4.9% of the company's shares are sold short.January 28, 2024 | marketbeat.comOptimizeRx Co. (NASDAQ:OPRX) Given Consensus Rating of "Moderate Buy" by BrokeragesOptimizeRx Co. (NASDAQ:OPRX - Get Free Report) has earned a consensus rating of "Moderate Buy" from the eight brokerages that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the compan Get OptimizeRx News Delivered to You Automatically Sign up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Crypto That You Don’t Own… Yet (Ad)There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening. Click here for all the details… OPRX Media Mentions By Week OPRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPRX News Sentiment▼1.880.65▲Average Computer and Technology News Sentiment OPRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPRX Articles This Week▼32▲OPRX Articles Average Week Get OptimizeRx News Delivered to You Automatically Sign up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Rimini Street News ZeroFox News DHI Group News Resources Connection News Zhihu News Edgio News Liquidity Services News Cass Information Systems News i3 Verticals News OLO News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPRX) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptimizeRx Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
